Inmune Bio (INMB) Exchange Rate Effect (2018 - 2026)
Inmune Bio (INMB) posted Exchange Rate Effect of $10000.0 for Q1 2026, down 72.97% sequentially from $37000.0 in Q4 2025, and up 128.57% YoY from $4375.0 in Q1 2025.
Inmune Bio (INMB) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Inmune Bio has reported Exchange Rate Effect for 9 years, with the latest figure at $10000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 128.57% year-over-year to $10000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$114000.0 (down 293.22% YoY) and the FY2025 annual result came in at -$159000.0, down 170.98% from the prior year.
- Exchange Rate Effect fell to $10000.0 in Q1 2026 per INMB's latest filing, from $37000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $461000.0 in Q4 2024 and troughed at -$757000.0 in Q2 2022.
- A 5-year average of -$42647.1 and a median of -$9000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect jumped 5400.0% in 2022, then tumbled 1304.35% in 2024.
- Over 5 years, Exchange Rate Effect stood at $443000.0 in 2022, then plunged by 114.45% to -$64000.0 in 2023, then surged by 820.31% to $461000.0 in 2024, then tumbled by 91.97% to $37000.0 in 2025, then plunged by 72.97% to $10000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $10000.0, $37000.0, and -$8000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Inmune Bio | 61.59 Mn | 43.18 Mn | - | -91,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -91,000.00 |
| Jun 30, 2026 | -91,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Mar 31, 2025 | -35,000.00 |
| Mar 31, 2025 | -35,000.00 |
| Dec 31, 2024 | 461,000.00 |
| Dec 31, 2024 | 461,000.00 |
| Sep 30, 2024 | -323,000.00 |
| Sep 30, 2024 | -323,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Mar 31, 2024 | 130,000.00 |